NCT01903070View on ClinicalTrials.gov

Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment

PHASE4CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

July 11, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Diabetes Mellitus
Interventions
DRUG

Linagliptin

Trial Locations (1)

41460

Profil Institut für Stoffwechselforschung GmbH, Neuss

All Listed Sponsors
lead

Profil Institut für Stoffwechselforschung GmbH

INDUSTRY

NCT01903070 - Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment | Biotech Hunter | Biotech Hunter